CDK13
Cyclin-dependent kinase 13
Also known as: CDC2L, CDC2L5, CDK13_HUMAN, CHED, KIAA1791
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14004
- Gene
- CDK13
- Ensembl
- ENSG00000065883
- Chromosome
- 7
- Canonical length
- 1512 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nuclear speckles,Golgi apparatus,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of the cyclin-dependent serine/threonine protein kinase family. Members of this family are well known for their essential roles as master switches in cell cycle control. The exact function of this protein has not yet been determined, but it may play a role in mRNA processing and may be involved in regulation of hematopoiesis. Alternatively spliced transcript variants have been described.[provided by RefSeq, Dec 2009]
Canonical amino-acid sequenceUniProt
1512 residues, UniProt reviewed canonical sequence.
>Q14004|CDK13
1 MPSSSDTALG GGGGLSWAEK KLEERRKRRR FLSPQQPPLL LPLLQPQLLQ PPPPPPPLLF
61 LAAPGTAAAA AAAAAASSSC FSPGPPLEVK RLARGKRRAG GRQKRRRGPR AGQEAEKRRV
121 FSLPQPQQDG GGGASSGGGV TPLVEYEDVS SQSEQGLLLG GASAATAATA AGGTGGSGGS
181 PASSSGTQRR GEGSERRPRR DRRSSSGRSK ERHREHRRRD GQRGGSEASK SRSRHSHSGE
241 ERAEVAKSGS SSSSGGRRKS ASATSSSSSS RKDRDSKAHR SRTKSSKEPP SAYKEPPKAY
301 REDKTEPKAY RRRRSLSPLG GRDDSPVSHR ASQSLRSRKS PSPAGGGSSP YSRRLPRSPS
361 PYSRRRSPSY SRHSSYERGG DVSPSPYSSS SWRRSRSPYS PVLRRSGKSR SRSPYSSRHS
421 RSRSRHRLSR SRSRHSSISP STLTLKSSLA AELNKNKKAR AAEAARAAEA AKAAEATKAA
481 EAAAKAAKAS NTSTPTKGNT ETSASASQTN HVKDVKKIKI EHAPSPSSGG TLKNDKAKTK
541 PPLQVTKVEN NLIVDKATKK AVIVGKESKS AATKEESVSL KEKTKPLTPS IGAKEKEQHV
601 ALVTSTLPPL PLPPMLPEDK EADSLRGNIS VKAVKKEVEK KLRCLLADLP LPPELPGGDD
661 LSKSPEEKKT ATQLHSKRRP KICGPRYGET KEKDIDWGKR CVDKFDIIGI IGEGTYGQVY
721 KARDKDTGEM VALKKVRLDN EKEGFPITAI REIKILRQLT HQSIINMKEI VTDKEDALDF
781 KKDKGAFYLV FEYMDHDLMG LLESGLVHFN ENHIKSFMRQ LMEGLDYCHK KNFLHRDIKC
841 SNILLNNRGQ IKLADFGLAR LYSSEESRPY TNKVITLWYR PPELLLGEER YTPAIDVWSC
901 GCILGELFTK KPIFQANQEL AQLELISRIC GSPCPAVWPD VIKLPYFNTM KPKKQYRRKL
961 REEFVFIPAA ALDLFDYMLA LDPSKRCTAE QALQCEFLRD VEPSKMPPPD LPLWQDCHEL
1021 WSKKRRRQKQ MGMTDDVSTI KAPRKDLSLG LDDSRTNTPQ GVLPSSQLKS QGSSNVAPVK
1081 TGPGQHLNHS ELAILLNLLQ SKTSVNMADF VQVLNIKVNS ETQQQLNKIN LPAGILATGE
1141 KQTDPSTPQQ ESSKPLGGIQ PSSQTIQPKV ETDAAQAAVQ SAFAVLLTQL IKAQQSKQKD
1201 VLLEERENGS GHEASLQLRP PPEPSTPVSG QDDLIQHQDM RILELTPEPD RPRILPPDQR
1261 PPEPPEPPPV TEEDLDYRTE NQHVPTTSSS LTDPHAGVKA ALLQLLAQHQ PQDDPKREGG
1321 IDYQAGDTYV STSDYKDNFG SSSFSSAPYV SNDGLGSSSA PPLERRSFIG NSDIQSLDNY
1381 STASSHSGGP PQPSAFSESF PSSVAGYGDI YLNAGPMLFS GDKDHRFEYS HGPIAVLANS
1441 SDPSTGPEST HPLPAKMHNY NYGGNLQENP SGPSLMHGQT WTSPAQGPGY SQGYRGHIST
1501 STGRGRGRGL PYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDK13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 26 nTPM
- lymph node: 19 nTPM
- thyroid gland: 18 nTPM
- retina: 18 nTPM
- tonsil: 17 nTPM
- testis: 17 nTPM
Single-cell type
- neutrophil progenitors: 421 nCPM
- myonuclei: 390 nCPM
- neutrophils: 327 nCPM
- microglia: 327 nCPM
- fibro-adipogenic progenitors: 316 nCPM
- thymocytes: 314 nCPM
Immune cell
- naive B-cell: 10 nTPM
- basophil: 7.4 nTPM
- memory B-cell: 6.2 nTPM
- neutrophil: 5.8 nTPM
- gdT-cell: 4 nTPM
- NK-cell: 4 nTPM
Brain region
- cerebellum: 79 nTPM
- white matter: 68 nTPM
- hypothalamus: 62 nTPM
- basal ganglia: 61 nTPM
- medulla oblongata: 60 nTPM
- cerebral cortex: 60 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CDK13.
Disease | AllUniProt
Conditions CDK13 is implicated in, by any mechanism.
- Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder (CHDFIDD) MIM:617360
Disease | GeneticClinVar
87 pathogenic / likely-pathogenic of 1,179 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder
- Inborn genetic diseases
- CDK13-related disorder
- Global developmental delay
- Marfanoid habitus and intellectual disability
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.91
- gnomAD missense Z
- 2.35
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- alternative mRNA splicing, via spliceosome
- hemopoiesis
- negative regulation of stem cell differentiation
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription elongation by RNA polymerase II
- regulation of signal transduction
Molecular functions
- ATP binding
- cyclin binding
- cyclin-dependent protein serine/threonine kinase activity
- protein kinase activity
- protein kinase binding
- protein serine kinase activity
- RNA binding
- RNA polymerase II CTD heptapeptide repeat kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDK13 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDK13 as an antibody target. Whether an autoantibody or antibody against CDK13 could matter depends on whether native CDK13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDK13 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDK13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...